<p>在 12 月 17 日，<strong>MARK ORDAN</strong>，<strong>Pediatrix Medical Group</strong>（纽约证券交易所代码：MD）的首席执行官，报告了一笔大规模的内部出售，基于最近的 SEC 文件。</p>
<p>** 发生了什么：**ORDAN 最近的举动涉及出售 23,000 股 <strong>Pediatrix Medical Group</strong> 的股票。这一信息在周三的美国证券交易委员会的 Form 4 文件中有记录。总价值为 515,430 美元。</p>
<p>在周四的早盘交易中，<strong>Pediatrix Medical Group</strong> 的股票下跌了 0.27%，目前价格为 22.5 美元。</p>
<h3>了解 Pediatrix Medical Group：更深入的观察</h3>
<p>Pediatrix Medical Group Inc 为医院、重症监护室和其他医疗单位提供医生服务。该公司提供的服务包括为孕妇提供母婴护理、为早产儿提供重症监护、为患有心脏缺陷的婴儿提供心脏病护理，以及在手术期间提供麻醉护理等。该公司仅在一个部门运营，提供包括新生儿、母胎和其他儿科专业护理的医生服务。它的收入主要来自新生儿学和其他儿科专业。</p>
<h3>财务洞察：Pediatrix Medical Group</h3>
<p><strong>收入挑战：</strong> 截至 2025 年 9 月 30 日，Pediatrix Medical Group 的收入增长面临困难。公司经历了约 <strong>-3.58%</strong> 的下降。这表明其收入出现了下滑。与竞争对手相比，该公司的增长率低于医疗保健行业的平均水平。</p>
<p><strong>分析盈利能力指标：</strong></p>
<ul>
<li>毛利率：该公司的毛利率为 28.48%，在成本效率和盈利能力方面优于行业同行。</li>
</ul>
<ul>
<li>每股收益（EPS）：Pediatrix Medical Group 的每股收益超出行业平均水平，当前每股收益为 0.85，显示出强劲的盈利趋势。</li>
</ul>
<p>** 债务管理：**Pediatrix Medical Group 的债务与股本比率低于行业标准，表明其财务结构稳健，比例为 <strong>0.72</strong>。</p>
<p><strong>估值指标：</strong></p>
<ul>
<li>市盈率（P/E）：Pediatrix Medical Group 的市盈率为 11.81，低于行业平均水平，暗示该股票可能被低估。</li>
</ul>
<ul>
<li>市销率（P/S）：市销率为 1.0，低于行业平均水平。这表明基于销售表现可能存在低估。</li>
</ul>
<ul>
<li>企业价值/息税折旧摊销前利润（EV/EBITDA）分析：该公司的 EV/EBITDA 比率为 8.01，低于行业平均水平，暗示可能被低估，这对价值投资者可能是有利的。</li>
</ul>
<p><strong>市值分析：</strong> 该公司的市值低于行业基准，反映出相对于同行的规模较小。这可能与增长预期或运营能力等因素有关。</p>
<p>现在通过查尔斯·施瓦布在线免佣金交易股票，这是一个值得信赖的全面投资公司。</p>
<h3>揭示内部活动的重要性</h3>
<p>投资者应将内部交易视为多方面分析的一部分，而不是仅仅依赖于它们进行决策。</p>
<p>在法律术语中，“内部人” 是指任何公司股权证券的官员、董事或持有超过 10% 权益的受益所有者，这些证券根据 1934 年证券交易法第 12 条注册。这可以包括高管和大型对冲基金。这些内部人需要通过 Form 4 文件向公众披露他们的交易，该文件必须在交易后的两个工作日内提交。</p>
<p>当公司内部人进行新购买时，这表明他们预计股票将会上涨。</p>
<p>另一方面，内部出售可能出于多种原因，并不一定意味着卖方认为股票会下跌。</p>
<h3>值得关注的交易代码</h3>
<p>在审查交易时，投资者 通常集中于在公开市场上进行的交易，这些交易在 Form 4 文件的表格 I 中详细列出。Box 3 中的 <strong>P</strong> 表示购买，而 <strong>S</strong> 表示出售。交易代码 <strong>C</strong> 表示期权的转换，交易代码 <strong>A</strong> 表示从公司获得的证券的授予、奖励或其他获取。</p>
<p>查看 Pediatrix Medical Group 内部交易的完整列表。</p>
<p><strong>内部购买警报：从 C-suite 的举动中获利</strong></p>
<p>Benzinga Edge 实时揭示每一笔内部交易。不要错过下一个由内部信心驱动的大幅股票变动。立即解锁这个终极情绪指标。点击这里获取访问权限。</p>
<p><em>本文由 Benzinga 的自动内容引擎生成，并由编辑审核。</em></p>

<p>根据 SEC 的 Form 4 文件，Pediatrix Medical Group 的首席执行官 Mark Ordan 出售了 23,000 股，价值 515,430 美元。此次内部交易于 12 月 17 日被报告。Pediatrix Medical Group 的股价下跌了 0.27%，至 22.5 美元。该公司提供医生服务，面临收入增长挑战，最近出现了-3.58% 的下降。尽管如此，它仍保持着强劲的毛利率和每股收益，且其市盈率和市销率显示出潜在的低估</p>

<p>A substantial insider sell was reported on December 17, by <strong>MARK ORDAN</strong>, Chief Executive Officer at <strong>Pediatrix Medical Group</strong> (NYSE: MD), based on the recent SEC filing.</p>
<div class="lb-trans"><p>在 12 月 17 日，<strong>MARK ORDAN</strong>，<strong>Pediatrix Medical Group</strong>（纽约证券交易所代码：MD）的首席执行官，报告了一笔大规模的内部出售，基于最近的 SEC 文件。</p>
</div><p><strong>What Happened:</strong> ORDAN's recent move involves selling 23,000 shares of <strong>Pediatrix Medical Group</strong>. This information is documented in a Form 4 filing with the U.S. Securities and Exchange Commission on Wednesday. The total value is $515,430.</p>
<div class="lb-trans"><p>** 发生了什么：**ORDAN 最近的举动涉及出售 23,000 股 <strong>Pediatrix Medical Group</strong> 的股票。这一信息在周三的美国证券交易委员会的 Form 4 文件中有记录。总价值为 515,430 美元。</p>
</div><p>During Thursday's morning session, <strong>Pediatrix Medical Group</strong> shares down by 0.27%, currently priced at $22.5.</p>
<div class="lb-trans"><p>在周四的早盘交易中，<strong>Pediatrix Medical Group</strong> 的股票下跌了 0.27%，目前价格为 22.5 美元。</p>
</div><h3>Discovering Pediatrix Medical Group: A Closer Look</h3>
<div class="lb-trans"><h3>了解 Pediatrix Medical Group：更深入的观察</h3>
</div><p>Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.</p>
<div class="lb-trans"><p>Pediatrix Medical Group Inc 为医院、重症监护室和其他医疗单位提供医生服务。该公司提供的服务包括为孕妇提供母婴护理、为早产儿提供重症监护、为患有心脏缺陷的婴儿提供心脏病护理，以及在手术期间提供麻醉护理等。该公司仅在一个部门运营，提供包括新生儿、母胎和其他儿科专业护理的医生服务。它的收入主要来自新生儿学和其他儿科专业。</p>
</div><h3>Financial Insights: Pediatrix Medical Group</h3>
<div class="lb-trans"><h3>财务洞察：Pediatrix Medical Group</h3>
</div><p><strong>Revenue Challenges:</strong> Pediatrix Medical Group's revenue growth over 3 months faced difficulties. As of 30 September, 2025, the company experienced a decline of approximately <strong>-3.58%</strong>. This indicates a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.</p>
<div class="lb-trans"><p><strong>收入挑战：</strong> 截至 2025 年 9 月 30 日，Pediatrix Medical Group 的收入增长面临困难。公司经历了约 <strong>-3.58%</strong> 的下降。这表明其收入出现了下滑。与竞争对手相比，该公司的增长率低于医疗保健行业的平均水平。</p>
</div><p><strong>Analyzing Profitability Metrics:</strong></p>
<div class="lb-trans"><p><strong>分析盈利能力指标：</strong></p>
</div><ul>
<li>Gross Margin: The company excels with a remarkable gross margin of 28.48%, indicating superior cost efficiency and profitability compared to its industry peers.</li>
</ul>
<div class="lb-trans"><ul>
<li>毛利率：该公司的毛利率为 28.48%，在成本效率和盈利能力方面优于行业同行。</li>
</ul>
</div><ul>
<li>Earnings per Share (EPS): Pediatrix Medical Group's EPS outshines the industry average, indicating a strong bottom-line trend with a current EPS of 0.85.</li>
</ul>
<div class="lb-trans"><ul>
<li>每股收益（EPS）：Pediatrix Medical Group 的每股收益超出行业平均水平，当前每股收益为 0.85，显示出强劲的盈利趋势。</li>
</ul>
</div><p><strong>Debt Management:</strong> Pediatrix Medical Group's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>0.72</strong>.</p>
<div class="lb-trans"><p>** 债务管理：**Pediatrix Medical Group 的债务与股本比率低于行业标准，表明其财务结构稳健，比例为 <strong>0.72</strong>。</p>
</div><p><strong>Valuation Metrics:</strong></p>
<div class="lb-trans"><p><strong>估值指标：</strong></p>
</div><ul>
<li>Price to Earnings (P/E) Ratio: Pediatrix Medical Group's P/E ratio of 11.81 is below the industry average, suggesting the stock may be undervalued.</li>
</ul>
<div class="lb-trans"><ul>
<li>市盈率（P/E）：Pediatrix Medical Group 的市盈率为 11.81，低于行业平均水平，暗示该股票可能被低估。</li>
</ul>
</div><ul>
<li>Price to Sales (P/S) Ratio: The Price to Sales ratio is 1.0, which is lower than the industry average. This suggests a possible undervaluation based on sales performance.</li>
</ul>
<div class="lb-trans"><ul>
<li>市销率（P/S）：市销率为 1.0，低于行业平均水平。这表明基于销售表现可能存在低估。</li>
</ul>
</div><ul>
<li>EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): Indicated by a lower-than-industry-average EV/EBITDA ratio of 8.01, the company suggests a potential undervaluation, which might be advantageous for value-focused investors.</li>
</ul>
<div class="lb-trans"><ul>
<li>企业价值/息税折旧摊销前利润（EV/EBITDA）分析：该公司的 EV/EBITDA 比率为 8.01，低于行业平均水平，暗示可能被低估，这对价值投资者可能是有利的。</li>
</ul>
</div><p><strong>Market Capitalization Analysis:</strong> Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.</p>
<div class="lb-trans"><p><strong>市值分析：</strong> 该公司的市值低于行业基准，反映出相对于同行的规模较小。这可能与增长预期或运营能力等因素有关。</p>
</div><p>Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</p>
<div class="lb-trans"><p>现在通过查尔斯·施瓦布在线免佣金交易股票，这是一个值得信赖的全面投资公司。</p>
</div><h3>Uncovering the Importance of Insider Activity</h3>
<div class="lb-trans"><h3>揭示内部活动的重要性</h3>
</div><p>Investors should view insider transactions as part of a multifaceted analysis and not rely solely on them for decision-making.</p>
<div class="lb-trans"><p>投资者应将内部交易视为多方面分析的一部分，而不是仅仅依赖于它们进行决策。</p>
</div><p>In legal terms, an &#34;insider&#34; refers to any officer, director, or beneficial owner of more than ten percent of a company's equity securities registered under Section 12 of the Securities Exchange Act of 1934. This can include executives in the c-suite and large hedge funds. These insiders are required to let the public know of their transactions via a Form 4 filing, which must be filed within two business days of the transaction.</p>
<div class="lb-trans"><p>在法律术语中，“内部人” 是指任何公司股权证券的官员、董事或持有超过 10% 权益的受益所有者，这些证券根据 1934 年证券交易法第 12 条注册。这可以包括高管和大型对冲基金。这些内部人需要通过 Form 4 文件向公众披露他们的交易，该文件必须在交易后的两个工作日内提交。</p>
</div><p>When a company insider makes a new purchase, that is an indication that they expect the stock to rise.</p>
<div class="lb-trans"><p>当公司内部人进行新购买时，这表明他们预计股票将会上涨。</p>
</div><p>Insider sells, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down.</p>
<div class="lb-trans"><p>另一方面，内部出售可能出于多种原因，并不一定意味着卖方认为股票会下跌。</p>
</div><h3>Transaction Codes Worth Your Attention</h3>
<div class="lb-trans"><h3>值得关注的交易代码</h3>
</div><p>Examining transactions, investors often concentrate on those unfolding in the open market, meticulously detailed in Table I of the Form 4 filing. A <strong>P</strong> in Box 3 denotes a purchase, while <strong>S</strong> signifies a sale. Transaction code <strong>C</strong> indicates the conversion of an option, and transaction code <strong>A</strong> denotes a grant, award, or other acquisition of securities from the company.</p>
<div class="lb-trans"><p>在审查交易时，投资者 通常集中于在公开市场上进行的交易，这些交易在 Form 4 文件的表格 I 中详细列出。Box 3 中的 <strong>P</strong> 表示购买，而 <strong>S</strong> 表示出售。交易代码 <strong>C</strong> 表示期权的转换，交易代码 <strong>A</strong> 表示从公司获得的证券的授予、奖励或其他获取。</p>
</div><p>Check Out The Full List Of Pediatrix Medical Group's Insider Trades.</p>
<div class="lb-trans"><p>查看 Pediatrix Medical Group 内部交易的完整列表。</p>
</div><p><strong>Insider Buying Alert: Profit from C-Suite Moves</strong></p>
<div class="lb-trans"><p><strong>内部购买警报：从 C-suite 的举动中获利</strong></p>
</div><p>Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. Click here for access.</p>
<div class="lb-trans"><p>Benzinga Edge 实时揭示每一笔内部交易。不要错过下一个由内部信心驱动的大幅股票变动。立即解锁这个终极情绪指标。点击这里获取访问权限。</p>
</div><p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>
<div class="lb-trans"><p><em>本文由 Benzinga 的自动内容引擎生成，并由编辑审核。</em></p>
</div>

马克·奥尔丹执行了卖出订单：出售了价值 51.5 万美元的 Pediatrix Medical Group 股票